ey0019.14-14 | New treatments | ESPEYB19
Zhukouskaya Volha V
, Jauze Louisa
, Charles Severine
, Leborgne Christian
, Hilliquin Stephane
, Sadoine Jeremy
, Slimani Lotfi
, Baroukh Brigitte
, van Wittenberghe Laetitia
, Daniele Natalie
, Rajas Fabienne
, Linglart Agnes
, Mingozzi Federico
, Chaussain Catherine
, Bardet Claire
, Ronzitti Giuseppe
Science Advances, 2021,7:eabj5018 doi: 10.1126/sciadv.abj5018Brief Summary: The authors developed a liver-targeting adeno-associated virus (AAV) vector carrying C-terminal FGF23 (cFGF23) to inhibit FGF23 signalling in a mouse model for X-linked hypophosphataemic rickets (hyp-duk mice). They were able to show that a single injection of AAV cFGF23 rescued the hyp-duk phenotype.<p class="abst...